These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 31036992

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The impact of chemotherapy-induced inner ear damage on quality of life in cancer survivors: a qualitative study.
    Pearson SE, Caimino C, Shabbir M, Baguley DM.
    J Cancer Surviv; 2022 Oct; 16(5):976-987. PubMed ID: 34398361
    [Abstract] [Full Text] [Related]

  • 5. Challenges in ototoxicity monitoring in the pediatric oncology population.
    Bass JK, Bhagat SP.
    J Am Acad Audiol; 2014 Sep; 25(8):760-74; quiz 782-3. PubMed ID: 25380122
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. An Ototoxicity Grading System Within a Mobile App (OtoCalc) for a Resource-Limited Setting to Guide Grading and Management of Drug-Induced Hearing Loss in Patients With Drug-Resistant Tuberculosis: Prospective, Cross-Sectional Case Series.
    Hollander C, Joubert K, Schellack N.
    JMIR Mhealth Uhealth; 2020 Jan 14; 8(1):e14036. PubMed ID: 31934875
    [Abstract] [Full Text] [Related]

  • 8. Clinical trials, ototoxicity grading scales and the audiologist's role in therapeutic decision making.
    King KA, Brewer CC.
    Int J Audiol; 2018 Sep 14; 57(sup4):S89-S98. PubMed ID: 29276851
    [Abstract] [Full Text] [Related]

  • 9. Hearing loss in a pediatric patient following cisplatin chemotherapy and subsequent exposure to excessive noise.
    Peleva E, Aloy E, Carret AS, Daniel SJ.
    Int J Pediatr Otorhinolaryngol; 2014 Dec 14; 78(12):2301-4. PubMed ID: 25439704
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
    van As JW, van den Berg H, van Dalen EC.
    Cochrane Database Syst Rev; 2012 May 16; (5):CD009219. PubMed ID: 22592737
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Ototoxicity monitoring through the eyes of the treating physician: Perspectives from pulmonology and medical oncology.
    Garinis AC, Cornell A, Allada G, Fennelly KP, Maggiore RJ, Konrad-Martin D.
    Int J Audiol; 2018 Sep 16; 57(sup4):S19-S24. PubMed ID: 28978238
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Drug-induced hearing loss as a manifestation of drug-induced ototoxicity].
    Ostroumova OD, Chikh EV, Rebrova EV, Ryazanova AY, Pereverzev AP.
    Vestn Otorinolaringol; 2019 Sep 16; 84(4):72-80. PubMed ID: 31579063
    [Abstract] [Full Text] [Related]

  • 17. Platinum-induced ototoxicity: a review of prevailing ototoxicity criteria.
    Waissbluth S, Peleva E, Daniel SJ.
    Eur Arch Otorhinolaryngol; 2017 Mar 16; 274(3):1187-1196. PubMed ID: 27245751
    [Abstract] [Full Text] [Related]

  • 18. Incidence and associated risk factors for platinum-induced ototoxicity in pediatric patients.
    Waissbluth S, Del Valle Á, Chuang A, Becker A.
    Int J Pediatr Otorhinolaryngol; 2018 Aug 16; 111():174-179. PubMed ID: 29958605
    [Abstract] [Full Text] [Related]

  • 19. Extended-interval aminoglycoside administration for children: a meta-analysis.
    Contopoulos-Ioannidis DG, Giotis ND, Baliatsa DV, Ioannidis JP.
    Pediatrics; 2004 Jul 16; 114(1):e111-8. PubMed ID: 15231982
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.